MM PD market growth will be driven by advancements in innovative therapies, including the first DMTs, and a growing patient ...

Inhibikase Therapeutics said on Wednesday it would stop development of its experimental Parkinson's disease drug after it failed to improve patients' ability to carry out daily tasks such as eating ...